Literature DB >> 9088778

Development of substance use and psychiatric comorbidity in an epidemiologic study of white and American Indian young adolescents the Great Smoky Mountains Study.

E B Federman1, E J Costello, A Angold, E M Farmer, A Erkanli.   

Abstract

The progression of substance use and the patterns of comorbidity of substance use and psychiatric disorders are explored prospectively in young adolescents enrolled in the Great Smoky Mountains Study. This study is an epidemiologic study of white and American Indian youths living in rural Southern Appalachia. Results from this study indicate that alcohol use without permission predicts subsequent use of illicit drugs and regular tobacco use. Use of tobacco was not associated with either later alcohol or drug use. Patterns of comorbidity showed strong cross-sectional relationships between substance use and behavioral disorders, but not emotional disorders. Use of alcohol was also associated with psychiatric diagnosis at a later interview. There were some differences between white and American Indian youths in the pattern of comorbidity of tobacco use and psychiatric disorder and the relationship between prior psychiatric disorder and later alcohol use. These findings suggest that alcohol use without permission may be an important marker for youths who are at risk for illicit drug use and/or psychiatric diagnoses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088778     DOI: 10.1016/s0376-8716(96)01317-8

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  22 in total

1.  Associations of family environment and individual factors with tobacco, alcohol, and illicit drug use in adolescents.

Authors:  B Challier; N Chau; R Prédine; M Choquet; B Legras
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

2.  Profiles of current disruptive behavior: association with recent drug consumption among adolescents.

Authors:  Carla L Storr; Veronica H Accornero; Rosa M Crum
Journal:  Addict Behav       Date:  2006-05-19       Impact factor: 3.913

3.  Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey.

Authors:  Robert E Roberts; Catherine Ramsay Roberts; Yun Xing
Journal:  Drug Alcohol Depend       Date:  2007-02-01       Impact factor: 4.492

4.  Substance Use Disorders, Comorbidity, and Arrest among Indigenous Adolescents.

Authors:  Kelley J Sittner Hartshorn; Les B Whitbeck; Patricia Prentice
Journal:  Crime Delinq       Date:  2006-12-06

Review 5.  Mood disorders and chronic obstructive pulmonary disease: current research and future needs.

Authors:  Greg L Clary; Scott M Palmer; P Murali Doraiswamy
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

6.  Does diversity matter? The need for longitudinal research on adolescent alcohol and drug use trajectories.

Authors:  Elizabeth J D'Amico; Joan S Tucker; Regina A Shih; Jeremy N V Miles
Journal:  Subst Use Misuse       Date:  2014-06       Impact factor: 2.164

7.  Alcohol use among American Indian high school youths from adolescence and young adulthood: a latent Markov model.

Authors:  Christina M Mitchell; Janette Beals; Nancy Rumbaugh Whitesell
Journal:  J Stud Alcohol Drugs       Date:  2008-09       Impact factor: 2.582

8.  Investigating Progression in Substance Use Initiation Using a Discrete-Time Multiple Event Process Survival Mixture (MEPSUM) Approach.

Authors:  Leah S Richmond-Rakerd; Kimberly A Fleming; Wendy S Slutske
Journal:  Clin Psychol Sci       Date:  2015-07-24

9.  Pathways from adolescent parent-child conflict to substance use disorders in the fourth decade of life.

Authors:  Judith S Brook; David W Brook; Chenshu Zhang; Patricia Cohen
Journal:  Am J Addict       Date:  2009 May-Jun

Review 10.  A systematic review of longitudinal studies on the association between depression and smoking in adolescents.

Authors:  Michael O Chaiton; Joanna E Cohen; Jennifer O'Loughlin; Jurgen Rehm
Journal:  BMC Public Health       Date:  2009-09-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.